MedCan Summit Speaker
Carmen Doran
Chief Executive Officer,
Helius TherapeuticsHelius Therapeutics is vertically-integrated and has a bold vision, to become a world leader in the research, development and marketing of next-generation medical cannabis products.
Carmen Doran, CEO, has a strong international background in pharmaceutical operations including site and global roles in both human and animal health. Carmen holds a Masters’ Degree in Biomedical Engineering from the University of Canterbury.
All Sessions by Carmen Doran
Day 1 - Industry Summit - 10 February |
Time | Industry Stream | Science Stream |
---|---|---|
10:05 | CEO panel: The state of play for New Zealand’s medicinal cannabis industry in 2022 and beyond
Manu Caddie, Co-Founder, Kaihautu – Innovation and Regulation, Rua Bioscience Carmen Doran Chief Executive Officer, Helius Therapeutics Mark Lucas Chief Executive Officer, Cannasouth Tim Aldridge Managing Director, Puro Mitch Cuevas Pharmaceutical Director, Eqalis | CEO panel: The state of play for New Zealand’s medicinal cannabis industry in 2022 and beyond
Manu Caddie, Co-Founder, Kaihautu – Innovation and Regulation, Rua Bioscience Carmen Doran Chief Executive Officer, Helius Therapeutics Mark Lucas Chief Executive Officer, Cannasouth Tim Aldridge Managing Director, Puro Mitch Cuevas Pharmaceutical Director, Eqalis |
11:20 | Industry Panel: Women in the medicinal cannabis industry Carmen Doran Chief Executive Officer, Helius Therapeutics Eva Neshat Founder and Chief Executive Officer, Elysian Pharmaceuticals & CannaPlus+ Zoë Reece Founder and CEO, Ora Pharm Dr Dottie Clower Chief Scientific Officer, Puro | |
12:20 | Science Fireside chat: Helping talent navigate through the sector Carmen Doran Chief Executive Officer, Helius Therapeutics Ali Seyfoddin Associate Professor of Drug Delivery and Biological Engineering Deputy Head of School, School of Science, Auckland University of Technology |
More Speakers
Director
Founder and CEO
List Member
Co-Founder and GM